J
Joep Thijssen
Researcher at Leiden University Medical Center
Publications - 35
Citations - 1404
Joep Thijssen is an academic researcher from Leiden University Medical Center. The author has contributed to research in topics: Implantable cardioverter-defibrillator & Cardiac resynchronization therapy. The author has an hindex of 23, co-authored 35 publications receiving 1246 citations. Previous affiliations of Joep Thijssen include Leiden University.
Papers
More filters
Journal ArticleDOI
Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices: A Systematic Review of Randomized Clinical Trials
Johannes B. van Rees,Mihály K. de Bie,Joep Thijssen,C. Jan Willem Borleffs,Martin J. Schalij,Lieselot van Erven +5 more
TL;DR: Eleven ICD and 7 CRT trials were systematically reviewed to provide data on the frequency of in-hospital mortality and complications related to the implantation.
Journal ArticleDOI
Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up
Ulas Höke,Dominique Auger,Joep Thijssen,Ron Wolterbeek,Enno T. van der Velde,Eduard R. Holman,Martin J. Schalij,Jeroen J. Bax,Victoria Delgado,Nina Ajmone Marsan +9 more
TL;DR: Significant lead-induced TR is associated with poor long-term prognosis and was independently associated with all-cause mortality and heart failure related events in a retrospective cohort of ICD or pacemaker recipients.
Journal ArticleDOI
The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
Aafke C van der Heijden,C. Jan Willem Borleffs,Maurits S Buiten,Joep Thijssen,Johannes B. van Rees,Suzanne C. Cannegieter,Martin J. Schalij,Lieselot van Erven +7 more
TL;DR: After long-term follow-up of ICD (12 years) and CRT-D (8 years) recipients, 49% of I CD recipients and 55% of CRT’s recipients had died and appropriate defibrillator therapy was received by the majority and by almost 40% of recipients.
Journal ArticleDOI
Cardiac device infections are associated with a significant mortality risk.
Mihály K. de Bie,Johannes B. van Rees,Joep Thijssen,C. Jan Willem Borleffs,Serge A. Trines,Suzanne C. Cannegieter,Martin J. Schalij,Lieselot van Erven +7 more
TL;DR: The occurrence of CDI was associated with substantial 1-year mortality, and patients experiencing CDI had a more than 2-fold increased risk of mortality compared with patients who remained free from CDI.
Journal ArticleDOI
Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients
Philippe Debonnaire,Joep Thijssen,Darryl P. Leong,Emer Joyce,Spyridon Katsanos,G.E. Hoogslag,Martin J. Schalij,Douwe E. Atsma,Jeroen J. Bax,Victoria Delgado,Nina Ajmone Marsan +10 more
TL;DR: LAVI and GLS provide high negative predictive value for appropriate ICD therapy in high-risk HCM patients, and both parameters may be useful to optimize criteria and timing for ICD implantation in these patients.